Search Results - "Elena Pegoraro"

Refine Results
  1. 1

    The "Usual Suspects": Genes for Inflammation, Fibrosis, Regeneration, and Muscle Strength Modify Duchenne Muscular Dystrophy by Bello, Luca, Pegoraro, Elena

    Published in Journal of clinical medicine (10-05-2019)
    “…Duchenne muscular dystrophy (DMD), the most severe form of dystrophinopathy, is quite homogeneous with regards to its causative biochemical defect, i.e.,…”
    Get full text
    Journal Article
  2. 2

    Muscle magnetic resonance characterization of STIM1 tubular aggregate myopathy using unsupervised learning by Lupi, Amalia, Spolaor, Simone, Favero, Alessandro, Bello, Luca, Stramare, Roberto, Pegoraro, Elena, Nobile, Marco Salvatore

    Published in PloS one (08-05-2023)
    “…Congenital myopathies are a heterogeneous group of diseases affecting the skeletal muscles and characterized by high clinical, genetic, and histological…”
    Get full text
    Journal Article
  3. 3

    Mutation in BAG3 causes severe dominant childhood muscular dystrophy by Selcen, Duygu, Muntoni, Francesco, Burton, Barbara K., Pegoraro, Elena, Sewry, Caroline, Bite, Anna V., Engel, Andrew G.

    Published in Annals of neurology (01-01-2009)
    “…Objective Myofibrillar myopathies (MFMs) are morphologically distinct but genetically heterogeneous muscular dystrophies in which disintegration of Z disks and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Genetic modifiers of ambulation in the cooperative international Neuromuscular research group Duchenne natural history study by Bello, Luca, Kesari, Akanchha, Gordish-Dressman, Heather, Cnaan, Avital, Morgenroth, Lauren P., Punetha, Jaya, Duong, Tina, Henricson, Erik K., Pegoraro, Elena, McDonald, Craig M., Hoffman, Eric P.

    Published in Annals of neurology (01-04-2015)
    “…Objective We studied the effects of LTBP4 and SPP1 polymorphisms on age at loss of ambulation (LoA) in a multiethnic Duchenne muscular dystrophy (DMD) cohort…”
    Get full text
    Journal Article
  6. 6

    The value of serum creatinine as biomarker of disease progression in spinal and bulbar muscular atrophy (SBMA) by Blasi, Lorenzo, Sabbatini, Daniele, Fortuna, Andrea, Querin, Giorgia, Martinelli, Ilaria, Vianello, Sara, Bertolin, Cinzia, Pareyson, Davide, Pennuto, Maria, Pegoraro, Elena, Bello, Luca, Sorarù, Gianni

    Published in Scientific reports (12-10-2023)
    “…Serum creatinine has been indicated as a potential marker of motor function in SBMA and results form previous longitudinal studies pointed to its decline over…”
    Get full text
    Journal Article
  7. 7

    Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients by Borgia, Doriana, Malena, Adriana, Spinazzi, Marco, Desbats, Maria Andrea, Salviati, Leonardo, Russell, Aaron P, Miotto, Giovanni, Tosatto, Laura, Pegoraro, Elena, Sorarù, Gianni, Pennuto, Maria, Vergani, Lodovica

    Published in Human molecular genetics (15-03-2017)
    “…Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disorder caused by polyglutamine expansion in the androgen receptor (AR) and characterized by the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The relevance of migraine in the clinical spectrum of mitochondrial disorders by Terrin, Alberto, Bello, Luca, Valentino, Maria Lucia, Caporali, Leonardo, Sorarù, Gianni, Carelli, Valerio, Maggioni, Ferdinando, Zeviani, Massimo, Pegoraro, Elena

    Published in Scientific reports (10-03-2022)
    “…Recent scientific evidence suggests a link between migraine and brain energy metabolism. In fact, migraine is frequently observed in mitochondrial disorders…”
    Get full text
    Journal Article
  10. 10

    Cored in the act: the use of models to understand core myopathies by Fusto, Aurora, Moyle, Louise A, Gilbert, Penney M, Pegoraro, Elena

    Published in Disease models & mechanisms (19-12-2019)
    “…The core myopathies are a group of congenital myopathies with variable clinical expression - ranging from early-onset skeletal-muscle weakness to later-onset…”
    Get full text
    Journal Article
  11. 11

    SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells by Vianello, Sara, Pantic, Boris, Fusto, Aurora, Bello, Luca, Galletta, Eva, Borgia, Doriana, Gavassini, Bruno F, Semplicini, Claudio, Sorarù, Gianni, Vitiello, Libero, Pegoraro, Elena

    Published in Human molecular genetics (01-09-2017)
    “…Glucocorticoids are beneficial in Duchenne muscular dystrophy (DMD). Osteopontin (OPN), the protein product of SPP1, plays a role in DMD pathology modulating…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E by Semplicini, Claudio, Vissing, John, Dahlqvist, Julia R, Stojkovic, Tanya, Bello, Luca, Witting, Nanna, Duno, Morten, Leturcq, France, Bertolin, Cinzia, DʼAmbrosio, Paola, Eymard, Bruno, Angelini, Corrado, Politano, Luisa, Laforêt, Pascal, Pegoraro, Elena

    Published in Neurology (28-04-2015)
    “…OBJECTIVE:To determine the clinical spectrum of limb-girdle muscular dystrophy 2E (LGMD2E) and to investigate whether genetic or biochemical features can…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20